24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

All regions

Lymphoma Industry, December 2014 Market Reports from Top Publishers

You might be interested in: Flow Cytometry, Hematology, Cancer, more »


 
1-20 of about 8 900 reports for Lymphoma

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2014

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

... Large cell lymphoma (alcl)- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing and collaboration details & other ...

Lymphoma Treatment Drugs Markets in China

Lymphoma Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • December 2014
  • by Asia Market Information & Development Company

... lymphoma treatment drugs markets in china china's demand for lymphoma treatment drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow ...

Janssen-Cilag SpA SWOT Analysis, Strategy, Revenues and Profits

Janssen-Cilag SpA SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Pulmonary fibrosis (ipf) and sarcoidosis. The company develops drugs for breast and ovary cancer, prostate cancer, the lymphomas and acute myeloid leukemia. It operates a subsidiary of johnson and johnson ...

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Key elements such as swot analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs. The leukemia & lymphoma society, inc. - Strategic swot ...

EpiZyme, Inc. (EPZM) - Financial and Strategic SWOT Analysis Review

EpiZyme, Inc. (EPZM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Modifying enzymes, and others. The company partners with celgene, glaxosmithkline, eisai, the leukemia & lymphoma society and multiple myeloma research foundation. Epizyme is headquartered in cambridge, massachusetts ...

Curis, Inc. (CRIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Curis, Inc. (CRIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... Healthcare, deals summary, 2008 to ytd 2014 9curis, inc., Pharmaceuticals & healthcare, deal details 10partnerships 10curis enters into co-development agreement with the leukemia & lymphoma ...

Acetylon Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Acetylon Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... And washington in the us and across europe. The company partners with celgene corporation, and the leukemia & lymphoma society. Acetylon is headquartered in boston, massachusetts, the us ...

Actinium Pharmaceuticals, Inc. (ATNM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Actinium Pharmaceuticals, Inc. (ATNM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... Of leukemias, lymphomas and multiple myeloma. Its clients include national cancer institution, american cancer society, leukemia & lymphoma society, leukemia research foundation, and dkms americas. Atnm ...

Lymphoma Drug Pathway Analyzer 2014

Lymphoma Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • November 2014
  • by Bioseeker

... Before. Its capabilities moves you beyond powerful competitive intelligence to an opportunity seeking tool which lets you, by means of both present and emerging scientific knowledge, analyze the lymphoma ...

 Hodgkin Lymphoma-API Insights, 2014

Hodgkin Lymphoma-API Insights, 2014

  • $ 1 250
  • Industry report
  • November 2014
  • by Delve Insight

... Evaluate the marketing status and exclusivity details of hodgkin lymphoma key products to exploit opportunities for generic drug development opportunities. - Key players in the pharmaceutical industry ...

About 1 300 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • April 2014
    28 pages
  • Cancer  

  • United States  

    North America  

View report >

23 Companies for Lymphoma

Read our Company Profiles

Celgene Corp.

United States

Novartis Inc.

Switzerland

Seattle Genetics Inc.

United States

Pharmacyclics Inc.

United States

Bristol-Myers Squibb Co.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.